Ekawan Yoosakul และผู้แต่งคนอื่นๆ. (2016) Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Irbesartan Formulation, Irbesartan GPO 150 mg Tablets and Aprovelฎ 150 mg Tablets, after Oral Administration to Healthy Thai Volunteers under Fasting Conditions. <i>Journal of Health Research</i>, <i>30</i>(3), 199.Ekawan Yoosakul และผู้แต่งคนอื่นๆ. "Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Irbesartan Formulation, Irbesartan GPO 150 mg Tablets and Aprovelฎ 150 mg Tablets, after Oral Administration to Healthy Thai Volunteers under Fasting Conditions". Journal of Health Research 30 (2016):199.Ekawan Yoosakul และผู้แต่งคนอื่นๆ. Comparative Randomized, Single Dose, Two-Way Crossover, Open-Label Study to Determine the Bioequivalence of Irbesartan Formulation, Irbesartan GPO 150 mg Tablets and Aprovelฎ 150 mg Tablets, after Oral Administration to Healthy Thai Volunteers under Fasting Conditions. Chulalongkorn University Press:ม.ป.ท. 2016.